Merck Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.22 Cr
as on 16-11-2024
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 27.30 Cr
as on 16-11-2024
- Revenue 1.06%
(FY 2023)
- Profit 4.67%
(FY 2023)
- Ebitda 1.77%
(FY 2023)
- Net Worth 20.40%
(FY 2023)
- Total Assets 18.85%
(FY 2023)
About Merck Life Science
The Corporate was formerly known as Millipore Asia Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.22 Cr.
The company currently has active open charges totaling ₹27.30 Cr.
Aditya Sharma and Dhananjay Singh serve as directors at the Company.
- CIN/LLPIN
U33100MH1986PTC221693
- Company No.
221693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Merck Life Science Private Limited offer?
Merck Life Science Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Aroma Chemicals, Speciality Chemicals, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Heptahydrate, Chemical Reagents & Catalysts, Inorganic Salts, Chemical Test Kits, Chemical Intermediates.
Who are the key members and board of directors at Merck Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhananjay Singh  | Managing Director | 19-Apr-2024 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aditya Sharma | Director | 04-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Merck Life Science.
Merck Life Science Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.06% increase. The company also saw a slight improvement in profitability, with a 4.67% increase in profit. The company's net worth Soared by an impressive increase of 20.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merck Life Science?
In 2022, Merck Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Jul 1997 | ₹24.00 Cr | Open |
State Bank Of India Creation Date: 26 Jul 1993 | ₹1.20 Cr | Open |
Canara Bank Creation Date: 24 Dec 1990 | ₹1.00 Cr | Open |
How Many Employees Work at Merck Life Science?
Merck Life Science has a workforce of 618 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merck Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merck Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
